Prime Medicine Inc.

Prime Medicine Inc.

World Rank (Jan-05-2024)
9,288
Market Cap (Jan-05-2024)
0.877 Billion USD
World Rank (Jul-30-2023)
7,043
Market Cap (Jul-30-2023)
1.443 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
PRME
Market Cap (Mar-08-2026)
0.72
Employee Count
137
Employee Count as of Date
As on 2021
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Business Sector
Healthcare
Biotechnology
Company Website
PRIME MEDICINE, INC.
Company Profile
PRIME MEDICINE, INC. is a biotechnology company. It delivers genetic therapies to address diseases by deploying gene editing technology. PRIME MEDICINE, INC. offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme, and a pegRNA. Headquarters is in USA.
IPO Year
2022
Nasdaq Sector
Health Care
Nasdaq Industry
Medicinal Chemicals and Botanical Products

Share